Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SON-1010 by Sonnet BioTherapeutics for Mesenchymal Tumor: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Mesenchymal Tumor. According to GlobalData, Phase...
SON-1010 by Sonnet BioTherapeutics for Solid Tumor: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
SON-1010 by Sonnet BioTherapeutics for Non-Small Cell Lung Cancer: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Non-Small Cell Lung Cancer. According to...
SON-1010 by Sonnet BioTherapeutics for Head And Neck Cancer: Likelihood of Approval
SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Head And Neck Cancer. According to...